Managing and Navigating Patients with Polycythemia VeraVideo Categories: Polycythemia Vera
Supported through funding from Incyte
As we learn more about a person’s genetic makeup, the more we are able to target medicines to his/her needs and benefit. With continued research, Dr. Stainthorpe explains, we will be able to identify markers that allow us to target medicines more precisely to get better performance and reduce waste.
Dr Agarwala provides his perspective on the importance of the Global Biomarkers Consortium, World Cutaneous Malignancies Congress and the journal Personalized Medicine in Oncology.